×
Hero Background

Coma Diagnosis and Treatment Companies

ID: MRFR/Pharma/3555-HCR
120 Pages
Rahul Gotadki
October 2025

Diagnosis and treatment of coma involve a complex interplay of medical expertise, technological advancements, and specialized care. Several companies play a crucial role in this field, contributing to the development of innovative technologies, diagnostic tools, and treatment modalities.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Coma Diagnosis and Treatment Market

Coma Diagnosis and Treatment Key Companies

 

Latest Coma Diagnosis and Treatment Companies Update


Siemens Healthineers Launched the Lumify, a portable and affordable ultrasound system, potentially improving access to brain scans for coma diagnosis in resource-limited settings.


GE Healthcare Developed the Discovery MR 750w scanner with advanced neuroimaging capabilities, offering enhanced detection of subtle brain abnormalities in comatose patients.


Philips Healthcare Introduced the BioSuite ICX monitor with integrated neuromonitoring features, allowing for continuous and comprehensive monitoring of comatose patients.


Brain Resource Company Received FDA approval for its NeuroPace RNS System, a brain stimulation device for treatment of drug-resistant epilepsy, which can have application in comas caused by seizure activity.


List of Coma Diagnosis and Treatment Key Companies in the Market



  • Fujifilm Holdings (Japan)

  • GE Healthcare (U.S.)

  • Siemens Healthcare(U.S.)

  • Philips Healthcare (U.S.)

  • Shimadzu Corporation (Japan)

  • Toshiba Medical Systems Corporation (Japan)

  • Carestream Health (U.S.)

  • Nihon Kohden Corporation (Japan)

  • Electrical Geodesics Inc. (U.S.)

  • Masimo Corporation (U.S.)

  • Hologic (U.S.)

  • Esaote (Italy)